Efficacy of a Topical Product Containing Purified Omental Lipids and Three Anti-Itching Compounds in the Treatment of Chronic Pruritus/Prurigo Nodularis in Elderly Subjects: A Prospective, Assessor-Blinded, 4-Week Trial with Transepidermal Water Loss and Optical Coherence Tomography Assessments

References

• Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7(7):535–547. doi:10.1038/nrn195016791143
   PubMed Web of Science ®Google Scholar
• Ständer S. Classification of itch In: Itch-Management in Clinical Practice. Vol. 50 Karger Publishers; 2016:1–4.
   Google Scholar
• Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol. 2011;147(10):1153–1156. doi:10.1001/archdermatol.2011.17821680760
   PubMedGoogle Scholar
• Ständer S, Zeidler C, Augustin M, et al. S2k Guidelines for the diagnosis and treatment of chronic pruritus–update–short version. J der Deutschen Dermatologischen Gesellschaft. 2017;15(8):860–872.
   Web of Science ®Google Scholar
• Pereira MP, Kremer AE, Mettang T, Staender S. Chronic pruritus in the absence of skin disease: pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2016;17(4):337–348. doi:10.1007/s40257-016-0198-027216284
   PubMed Web of Science ®Google Scholar
• Valdes-Rodriguez R, Stull C, Yosipovitch G. Chronic pruritus in the elderly: pathophysiology, diagnosis and management. Drugs Aging. 2015;32(3):201–215. doi:10.1007/s40266-015-0246-025693757
   PubMed Web of Science ®Google Scholar
• Liautaud B, Pape JW, DeHovitz JA, et al. Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol. 1989;125(5):629–632. doi:10.1001/archderm.1989.016701700430052712583
   PubMedGoogle Scholar
• Pereira MP, Steinke S, Zeidler C, et al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32(7):1059–1065. doi:10.1111/jdv.1457028857299
   PubMed Web of Science ®Google Scholar
• Zeidler C, Tsianakas A, Pereira M, Ständer H, Yosipovitch G, Ständer S. Chronic prurigo of nodular type: a review. Acta Derm Venereol. 2018;98(1–2):173–179. doi:10.2340/00015555-277429135018
   PubMed Web of Science ®Google Scholar
• Norman RA. Xerosis and pruritus in the elderly: recognition and management. Dermatol Ther. 2003;16(3):254–259. doi:10.1046/j.1529-8019.2003.01635.x14510882
   PubMedGoogle Scholar
• Harding R, Mayo C, Rawlings A. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res. 1996;288(12):765–770. doi:10.1007/BF025052948950457
   PubMed Web of Science ®Google Scholar
• Patel T, Yosipovitch G. The management of chronic pruritus in the elderly. Skin Therapy Lett. 2010;15(8):5–9.
   Google Scholar
• Romanelli M, Dini V, Milani M. Topical purified omental lipid formulations in the prevention of skin ulcers: a narrative review. J Wound Care. 2019;28(5):284–290. doi:10.12968/jowc.2019.28.5.28431067163
   PubMed Web of Science ®Google Scholar
• Milani M, Federici A, Federici G. Purified omental lipids (pol) in the treatment of skin dryness in type 2 diabetic subjects with or without vascular or neurological complications: a prospective, controlled, assessor-blinded trial. J Clin Exp Dermatol Res. 2016;7(365):2. doi:10.4172/2155-9554.1000365
   Google Scholar
• Freitag G, Höoppner T. Results of a post marketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin. 1997;13(9):529–537. doi:10.1185/030079997091133269169255
   PubMed Web of Science ®Google Scholar
• Varothai S, Winayanuwattikun W, Phaitoonwattanakij S, Kasemsarn P, Boonchai W. An investigator‐blinded, randomized, prospective, comparative study of efficacy of four anti‐inflammatory and barrier hand moisturizers in patients with chronic hand dermatitis. Dermatol Ther. 2018;31(5):e12670. doi:10.1111/dth.1267030175539
   PubMed Web of Science ®Google Scholar
• Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors. Pain. 2008;139(3):541–550. doi:10.1016/j.pain.2008.06.00318602217
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Soldovieri MV, Russo C, Taglialatela M. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide. Br J Pharmacol. 2013;168(6):1430–1444. doi:10.1111/bph.1202923083124
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Bíró T. A TR (I) P to pruritus research: role of TRPV3 in inflammation and itch. J Invest Dermatol. 2009;129(3):531–535. doi:10.1038/jid.2008.44019209153
   PubMed Web of Science ®Google Scholar
• Ostadhadi S, Nikoui V, Haj-Mirzaian A, Kordjazy N, Dehpour AR. The role of PPAR-gamma receptor in pruritus. Eur J Pharmacol. 2015;762:322–325. doi:10.1016/j.ejphar.2015.06.00926057695
   PubMed Web of Science ®Google Scholar
• Kircik L. A nonsteroidal lamellar matrix cream containing palmitoylethanolamide for the treatment of atopic dermatitis. J Drugs Dermatol. 2010;9(4):334–338.20514790
   PubMed Web of Science ®Google Scholar
• General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14.25951678
   PubMedGoogle Scholar
• Reich A, Chatzigeorkidis E, Zeidler C, et al. Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol. 2017;97(6):759–760. doi:10.2340/00015555-264228224165
   PubMed Web of Science ®Google Scholar
• Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012;92:502–507. doi:10.2340/00015555-124622170091
   PubMed Web of Science ®Google Scholar
• Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1990;22(3):164–178. doi:10.1111/j.1600-0536.1990.tb01553.x2335090
   PubMed Web of Science ®Google Scholar
• Welzel J. Optical coherence tomography in dermatology: a review. Skin Research and Technology: review article. Skin Res Technol. 2001;7(1):1–9. doi:10.1034/j.1600-0846.2001.007001001.x11301634
   PubMed Web of Science ®Google Scholar
• Gambichler T, Moussa G, Sand M, Sand D, Altmeyer P, Hoffmann K. Applications of optical coherence tomography in dermatology. J Dermatol Sci. 2005;40(2):85–94. doi:10.1016/j.jdermsci.2005.07.00616139481
   PubMed Web of Science ®Google Scholar
• Ständer S, Yosipovitch G, Legat FJ, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med. 2020;382(8):706–716. doi:10.1056/NEJMoa190831632074418
   PubMed Web of Science ®Google Scholar
• Boozalis E, Khanna R, Zampella JG, Kwatra SG. Tricyclic antidepressants for the treatment of chronic pruritus. J Dermatol Treatment. 2019;1–3.
   Web of Science ®Google Scholar
• Yosipovitch G, Greaves MW. Definitions of itch. Basic Clin Dermatol. 2004;27:1–4.
   Google Scholar
• Berger TG, Steinhoff M. Pruritus in elderly patients—eruptions of senescence. Semin Cutan Med Surg. 2011;30(2):113. doi:10.1016/j.sder.2011.04.00221767773
   PubMed Web of Science ®Google Scholar
• Williams KA, Huang AH, Belzberg M, Kwatra SG. Prurigo nodularis: pathogenesis and management. J Am Acad Dermatol. 2020;83(6):1567–1575. doi:10.1016/j.jaad.2020.04.18232461078
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Abate LE, Yosipovitch G, Friedman AJ. A systematic review of evidence-based treatments for prurigo nodularis. J Am Acad Dermatol. 2019;80(3):756–764. doi:10.1016/j.jaad.2018.09.02030261199
   PubMed Web of Science ®Google Scholar
• Saraceno R, Chiricozzi A, Nisticò SP, Tiberti S, Chimenti S. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis. J Dermatol Treatment. 2010;21(6):363–366. doi:10.3109/09546630903386606
   PubMed Web of Science ®Google Scholar
• Reich A, Riepe C, Anastasiadou Z, et al. Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch. Acta Derm Venereol. 2016;96(7):978–980. doi:10.2340/00015555-243327068455
   PubMed Web of Science ®Google Scholar
• Ständer S, Kwon P, Hirman J, Perlman AJ, Weisshaar E, Metz M, TCP-102 Study Group. Serlopitant reduced pruritus in patients with prurigo nodularis in a Phase 2, randomized, placebo-controlled trial. J Am Acad Dermatol. 2019;80(5):1395–1402. doi:10.1016/j.jaad.2019.01.05230894279
   PubMed Web of Science ®Google Scholar
• Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F. A Phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020;382(3):222–232. doi:10.1056/NEJMoa191277031702883
   PubMed Web of Science ®Google Scholar
• Simon D, Nobbe S, Nägeli M, et al. Short‐and long‐term effects of two emollients on itching and skin restoration in xerotic eczema. Dermatol Ther. 2018;31(6):e12692. doi:10.1111/dth.1269230246910
   PubMed Web of Science ®Google Scholar
• Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs. 2009;18(14):872–877. doi:10.12968/bjon.2009.18.14.4335619633599
   PubMedGoogle Scholar
• Yosipovitch G, Misery L, Proksch E, Metz M, Staender S, Schmelz M. Skin barrier damage and itch: review of mechanisms, topical management and future directions. Acta Derm Venereol. 2019;99(13):1201–1209. doi:10.2340/00015555-329631454051
   PubMed Web of Science ®Google Scholar
• Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N‐palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol. 2008;22(1):73–82. doi:10.1111/j.1468-3083.2007.02351.x18181976
   PubMed Web of Science ®Google Scholar
• Lawton S. Practical issues for emollient therapy in dry and itchy skin. Br J Nurs. 2009;18(16):978–984. doi:10.12968/bjon.2009.18.16.4396419773688
   PubMedGoogle Scholar
• Lawton S. Skin barrier function and the use of emollients in dermatological nursing. Br j Nurs. 2007;16(12):712–719. doi:10.12968/bjon.2007.16.12.2372117851359
   PubMedGoogle Scholar
• Hawro T, Fluhr JW, Mengeaud V, et al. Polidocanol inhibits cowhage‐but not histamine‐induced itch in humans. Exp Dermatol. 2014;23(12):922–923. doi:10.1111/exd.1255525265889
   PubMed Web of Science ®Google Scholar
• Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci. 2009;30(8):411–420. doi:10.1016/j.tips.2009.05.00419608284
   PubMed Web of Science ®Google Scholar